Showing results (211-220 of 537) with videos related to

Sort By:
Pageof 54
Journal of Occupational and Environmental Medicine|January 16, 2004
Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and modelWilliam C Gerth, Syam Sarma, X Henry Hu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 9, 2017
CGRP Monoclonal Antibodies for Migraine: Rationale and ProgressHsiangkuo Yuan, Clinton G Lauritsen, Eric A Kaiser, et al.
BMC Neurology|October 26, 2022
Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studiesPatricia Pozo-Rosich, David W Dodick, Anders Ettrup, et al.
Pain Physician|September 20, 2011
Occipital nerve stimulation with the Bion® microstimulator for the treatment of medically refractory chronic cluster headacheNatalie H Strand, Terrence L Trentman, Bert B Vargas, et al.
Headache|April 29, 2006
Acute migraine treatment: patterns of use and satisfaction in a clinical populationShahram N Malik, Mary Hopkins, William B Young, et al.
Neurology|February 13, 2002
Migraine and autonomic nervous system function: a population-based, case-control studyAaron Shechter, Walter F Stewart, Stephen D Silberstein, et al.
Headache|January 31, 2019
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine HeadachesStewart J Tepper, David W Dodick, Peter C Schmidt, et al.
CNS Drugs|December 8, 2004
Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tabletEgilius L H Spierings, Alan M Rapoport, David W Dodick, et al.
Cephalalgia : an International Journal of Headache|October 13, 2010
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptanDavid W Dodick, James Kost, Christopher Assaid, et al.
Eneurologicalsci|May 30, 2023
Advocacy for patients with headache disordersRiadh Gouider, Deborah Henscheid Lorenz, Audrey Craven, et al.
Pageof 54